---
$id: https://graph.org.ai/products/commodity/51284120
$type: Product
source: UNSPSC
code: "51284120"
title: "Ceftizoxime"
class: "51284100"
classTitle: "Third generation cephalosporins"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ceftizoxime

**UNSPSC Code**: 51284120
**Class**: [Third generation cephalosporins](Third generation cephalosporins.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-bacterial agent with the molecular formula C13H13N5O5S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C43C467DPE, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, (6r-(6alpha,7beta(z)))- but generally known as ceftizoxime, which bears US NIH Compound Identifier 6533629. European Medicines Agency schedules Ceftizoxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07429MIG. The term CEFTIZOXIME is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules ceftizoxime in its Anatomical Therapeutic Chemical (ATC) Classification. CEFTIZOXIME is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ceftizoxime under HS 29419000 and SITC 54139. As of Q4 2014, CEFTIZOXIME remains the US FDA Preferred Term for this commodity. Ceftizoxime bears US NLM identifiers UMLS ID C0007560 and NCI Concept Code C61668. SMILES: S1C2N(C(=O)C2NC(=O)/C(=N\OC)C2NC(SC2)N)C(=CC1)C(=O)O.

